Treatment
Drug clinical trials
We’re tracking 1,253 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06918912RecruitingPhase 2
Loncastuximab tesirine for lymphoma after CAR-T therapy
This trial tests a drug called loncastuximab tesirine for people with diffuse large B-cell lymphoma or high-grade B-cell lymphoma that has come back or not responded after CAR-T cell therapy. It aims to see if the drug can help when other treatments have stopped working.
Alessandria, ALESSANDRIAAges 18–99 - NCT06572085RecruitingPhase 4
Butylphthalide for brain protection after cardiac arrest
This trial tests a medicine called butylphthalide (NBP) to see if it helps protect the brain after a cardiac arrest. It is for adults who remained unconscious after their heart was restarted.
Beijing, Beijing MunicipalityAges 18–80 - NCT04260477RecruitingPhase 3
Testing a new stronger TB retreatment medicine schedule
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
NiameyAges Any age - NCT07209761RecruitingPhase 3
New drug combo for drug-resistant TB (quabodepistat)
This study tests a new oral medication combination (quabodepistat with other drugs) for people with drug-resistant pulmonary TB. It aims to find a shorter, safer, and more effective treatment.
Beijing, Beijing MunicipalityAges 14 years+ - NCT06573489RecruitingPhase 4
Fospropofol for laparoscopic surgery safety study
This trial tests a sedative called fospropofol during laparoscopic abdominal surgery. It aims to see if it's safe and effective for adults with longer operations.
Wuhan, HubeiAges 18–65 - NCT07198074RecruitingPhase 3
Testing Avastin added to chemo plus Keytruda for certain endometrial cancer
This study tests adding Avastin (bevacizumab) to the standard combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (Keytruda) for advanced or recurrent endometrial cancer with a specific genetic makeup (pMMR and TP53 mutation). The goal is to see if adding Avastin helps shrink tumors or slow their growth.
Birmingham, AlabamaAges 18 years+ - NCT06939387Recruiting
Model for drug-induced kidney injury
This study builds a model to understand kidney injury caused by medications. It may help doctors better predict and manage drug-related kidney damage.
Hangzhou, ZhejiangAges Any age - NCT06938750Recruiting
New device study for ICU drug delivery
This trial tests a new medical device that gives medication to patients in the intensive care unit (ICU). It aims to see if the device works safely and effectively.
Pamplona, NavarreAges 1 year+ - NCT07200830RecruitingPhase 3
Testing different schedules of a targeted radiation drug for advanced prostate cancer
This trial tests two different dosing schedules of a drug called Lutetium-177 PSMA RLT, which delivers radiation directly to prostate cancer cells. It is for men with advanced prostate cancer that has stopped responding to hormone therapy and has spread, who have not yet had chemotherapy for this stage of the disease.
Anchorage, AlaskaAges 18 years+ - NCT07198217RecruitingPhase 2
Chemo, radiation, and immunotherapy for lung cancer
This trial tests a combination of platinum-based chemotherapy, large fractionated radiotherapy, and the immunotherapy drug tislelizumab for people with stage IIIB to IV non-squamous non-small cell lung cancer. It aims to see if this approach can help control the cancer without certain gene mutations.
Zibo, ShandongAges 18–75 - NCT07196410RecruitingPhase 1
A study of KAN-004 for diarrhea or colitis from immunotherapy
This trial tests a new treatment, KAN-004, for people with diarrhea or colon inflammation caused by cancer immunotherapy. It aims to help manage these side effects.
Montreal, QuebecAges 18 years+ - NCT07198659RecruitingEarly Phase 1
New immune cell therapy for advanced pancreatic cancer
This trial tests a new treatment using your own immune cells (called neutrophils) that are loaded with a drug to fight pancreatic cancer that cannot be removed by surgery. It may be an option if standard treatments have stopped working or caused bad side effects.
Xi’an, ShanxiAges 18–70 - NCT07201311RecruitingPhase 2
Stomach decontamination for severe poisoning in the ICU
This trial tests whether giving activated charcoal plus emptying the stomach can help people who are on a breathing machine after severe poisoning. It may lower the amount of poison in the body and improve recovery.
ParisAges 18 years+ - NCT07193862RecruitingEarly Phase 1
Testing a tiny device to find best treatments for liver tumors
This study tests a tiny device that is placed in your liver tumor during surgery. It checks how well different chemotherapy drugs work on your specific cancer, which may help your doctor choose the best treatment for you.
Lake Success, New YorkAges 18 years+ - NCT07198230Recruiting
DEB-TACE therapy for large lymphoma tumors that have returned or not responded
This trial tests a second-line treatment called DEB-TACE (tiny beads filled with chemo placed directly into the tumor's blood supply) for people with large, hard-to-treat lymphoma tumors that have come back or not responded to other therapies. If you have at least one big tumor with good blood supply and have tolerated doxorubicin chemo before, this might be an option.
Fuzhou, FujianAges 18–75 - NCT05454527Recruiting
Biobank study follow-up for adults with inflammatory muscle disease
This study follows adults who have (or are being evaluated for) inflammatory muscle conditions to collect health data and genetic test information. It may help researchers better understand these diseases and improve future care.
ParisAges 18 years+ - NCT05578586Recruiting
Study testing how to give meropenem in the ICU
This pilot study looks at the best way to give meropenem antibiotic to ICU patients with a serious suspected or confirmed infection. It may help improve treatment timing and dosing to fight infection while in intensive care.
OsloAges 18 years+ - NCT06431308Recruiting
Dietary help for weight-loss drug side effects
This study is testing whether a special diet can help reduce stomach side effects (like nausea or vomiting) from weight-loss medications such as Wegovy or Mounjaro. It is for people who are about to start or are taking these medications.
ArielAges 18 years+ - NCT07191860Recruiting
Coated balloon for non-cancerous airway narrowing
This trial tests a special balloon coated with a medicine (paclitaxel) to open narrowed windpipes. It is for people whose windpipe is blocked by scar tissue from a ventilator, transplant, or other non-cancer causes, not from cancer.
Baltimore, MarylandAges 22 years+ - NCT07186127Recruiting
Methotrexate for ectopic pregnancy with certain risks
This study looks at using methotrexate (a medication) to treat ectopic pregnancy (a pregnancy outside the uterus) in women who have some health issues that might make the usual treatment riskier. It aims to see how well methotrexate works for them.
Istanbul, TürkiyeAges 18–48 - NCT07191171Recruiting
Gut bacteria drugs and immunotherapy in lung cancer
This study looks at whether certain drugs (like antibiotics or other gut-bacteria-affecting medications) influence how well immunotherapy works for advanced non-small cell lung cancer. It may help find ways to improve treatment outcomes.
StrasbourgAges 18 years+ - NCT07193069Recruiting
Metformin overdose in the ICU – signs and dapagliflozin effects
This study looks at patients who are in the ICU after taking too much metformin (a diabetes drug), sometimes along with another drug called dapagliflozin (Farxiga). The goal is to understand how overdose affects the body and what signs doctors should watch for.
Saint-Denis, FranceAges 18 years+ - NCT07189364Enrolling by invitation
Comparing antibiotic prescribing to help doctors improve
This trial tests whether giving doctors a report comparing their antibiotic prescribing to their peers can improve how antibiotics are used. If you are a general medicine patient who stayed in the hospital for a short time, this study may help make antibiotic use safer and more effective.
Toronto, OntarioAges 18 years+ - NCT07190781Enrolling by invitation
Building a stent registry for unruptured brain aneurysms
This trial is collecting information from people who already received a specific type of stent (Lattice Flow-Diverting Dense-Mesh Stent) to treat an unruptured brain aneurysm. The goal is to learn how well the stent works and improve future treatments.
Beijing, Beijing MunicipalityAges 18–80
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,253 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.